Bessemer Group’s Elanco Animal Health ELAN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$64K Buy
2,577
+472
+22% +$10.9K ﹤0.01% 1628
2026
Q1
$50K Buy
2,105
+525
+33% +$12.8K ﹤0.01% 1673
2025
Q4
$36K Buy
1,580
+442
+39% +$9.62K ﹤0.01% 1721
2025
Q3
$24K Buy
1,138
+922
+427% +$15.4K ﹤0.01% 1636
2025
Q2
$3K Hold
216
﹤0.01% 2126
2025
Q1
$2K Buy
+216
New +$2.44K ﹤0.01% 2218
2023
Q1
Sell
-680
Closed -$8K 1946
2022
Q4
$8K Sell
680
-3,565
-84% -$44.4K ﹤0.01% 1466
2022
Q3
$53K Buy
4,245
+3,975
+1,472% +$69.5K ﹤0.01% 1152
2022
Q2
$6K Sell
270
-113
-30% -$2.67K ﹤0.01% 1476
2022
Q1
$10K Hold
383
﹤0.01% 1379
2021
Q4
$11K Sell
383
-875
-70% -$27.2K ﹤0.01% 1390
2021
Q3
$40K Buy
1,258
+857
+214% +$28.8K ﹤0.01% 1102
2021
Q2
$14K Buy
401
+18
+5% +$594 ﹤0.01% 1284
2021
Q1
$11K Buy
+383
New +$11.8K ﹤0.01% 1281
2019
Q4
Sell
-375
Closed -$10K 1663
2019
Q3
$10K Sell
375
-3,686,846
-100% -$111M ﹤0.01% 1476
2019
Q2
$125M Buy
+3,687,221
New +$120M 0.42% 73

Other funds holding ELAN

Bessemer Group's ELAN Position: Q2 2026 in Review

Bessemer Group increased its Elanco Animal Health (ELAN) stake by 22% in Q2 2026, buying an estimated $10.9K and bringing the position to 2,577 shares worth $64K. The position accounts for ﹤0.01% of the portfolio, ranked #1628.

Bessemer Group first reported a position in ELAN in Q2 2019 and has held it in 16 quarters since. The position peaked at $125M in Q2 2019. 522 funds tracked by Wall St. Rank hold ELAN as of Q2 2026.

  • Bessemer Group held 2,577 shares of Elanco Animal Health worth $64K as of Q2 2026.
  • Bessemer Group bought 472 Elanco Animal Health shares in Q2 2026, an estimated $10.9K.
  • Elanco Animal Health made up ﹤0.01% of Bessemer Group's portfolio in Q2 2026, its #1628 holding.
  • Bessemer Group first reported a position in Elanco Animal Health in Q2 2019 and has held it in 16 quarters since.
  • Bessemer Group's Elanco Animal Health position peaked at $125M in Q2 2019.
  • 522 funds tracked by Wall St. Rank held Elanco Animal Health as of Q2 2026.

Based on Bessemer Group's 13F filing for Q2 2026, filed 12 Aug 2026.